Loring Wolcott & Coolidge Fiduciary Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$416	Hold
2024 Q4	$818	Sell
2024 Q3	$3.43K	Buy